drugset / Trial / NCT05911594
IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to Monotherapy
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aimed to evaluate the outcome of simultaneous intradetrusor BOTOX (IDB) injection and Percutaneous tibial nerve stimulation (PTNS) for management of children with recurrent wetness since at least 6 months.
Timeline
- Start
- 2022-02-14
- Primary completion
- 2023-02-14
- Completion
- 2023-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Other |
| Subject | Solifenacin | Small molecule | 5 mg | — |
Indications
No indication recorded.